About eXmoor
eXmoor is a company based in Bristol (United Kingdom) founded in 2004.. eXmoor has raised $51.75 million across 2 funding rounds from investors including MVM Partners and Kineticos. eXmoor offers products and services including Process Development, GMP Manufacture, Fill and Finish, and QP Release. eXmoor operates in a competitive market with competitors including Orgenesis, Ori Biotech, MaSTherCell, Cognate Bioservices and Cell-Easy, among others.
- Headquarter Bristol, United Kingdom
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Exmoor Pharma Concepts Limited
- Date of Incorporation 03 Mar, 2004
- Jurisdiction TAUNTON, SOMERSET, UNITED KINGDOM
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$51.75 M (USD)
in 2 rounds
-
Latest Funding Round
$35 M (USD), Series A
May 30, 2023
-
Investors
MVM Partners
& 1 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of eXmoor
eXmoor offers a comprehensive portfolio of products and services, including Process Development, GMP Manufacture, Fill and Finish, and QP Release. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Early stage support for therapy development and scale-up
Production of viral vectors and cell therapies
Final packaging and quality release of therapies
Certification for regulatory compliance in therapies
Unlock access to complete
Funding Insights of eXmoor
eXmoor has successfully raised a total of $51.75M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $35 million completed in May 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series A — $35.0M
-
First Round
First Round
(11 Mar 2021)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2023 | Amount | Series A - eXmoor | Valuation |
investors |
|
| Mar, 2021 | Amount | Series A - eXmoor | Valuation | MVM |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in eXmoor
eXmoor has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include MVM Partners and Kineticos. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity investments in healthcare companies are managed.
|
Founded Year | Domain | Location | |
|
Invests in early-stage life sciences companies for innovation, expertise, and growth.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by eXmoor
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - eXmoor
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Exmoor Comparisons
Competitors of eXmoor
eXmoor operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Orgenesis, Ori Biotech, MaSTherCell, Cognate Bioservices and Cell-Easy, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Cell and gene therapies for multiple disorders are developed.
|
|
| domain | founded_year | HQ Location |
Software development services are provided for the biopharma sector.
|
|
| domain | founded_year | HQ Location |
Services for cell therapy development and manufacturing are provided.
|
|
| domain | founded_year | HQ Location |
Development and manufacturing services for cell-based therapies are provided.
|
|
| domain | founded_year | HQ Location |
Stem cell-based therapy services for research solutions are provided.
|
|
| domain | founded_year | HQ Location |
A biotechnology company focused on anti-aging therapeutics development.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Exmoor
Frequently Asked Questions about eXmoor
When was eXmoor founded?
eXmoor was founded in 2004 and raised its 1st funding round 17 years after it was founded.
Where is eXmoor located?
eXmoor is headquartered in Bristol, United Kingdom. It is registered at Bristol, England, United Kingdom.
Is eXmoor a funded company?
eXmoor is a funded company, having raised a total of $51.75M across 2 funding rounds to date. The company's 1st funding round was a Series A of $16.75M, raised on Mar 11, 2021.
What does eXmoor do?
eXmoor was founded in 2004 and is based in Bristol, United Kingdom. Cell and gene therapeutic services are delivered by the company to support the biopharmaceutical sector. Operations encompass development and manufacturing processes for advanced therapies. Focus is placed on regulatory compliance and scalable solutions for client needs in the United Kingdom and beyond. Expertise is applied to streamline therapeutic pipelines for pharmaceutical partners.
Who are the top competitors of eXmoor?
eXmoor's top competitors include Ori Biotech, MaSTherCell and OBiO Technology.
What products or services does eXmoor offer?
eXmoor offers Process Development, GMP Manufacture, Fill and Finish, and QP Release.
Who are eXmoor's investors?
eXmoor has 2 investors. Key investors include MVM Partners, and Kineticos.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.